Events & Presentations Fourth Quarter and Full Year 2025 Financial Results Earnings Call Recent Presentations Lineage Cell Therapeutics Corporate Overview (May 12, 2026) OpRegen® 3 Year Clinical Data Update (Retinal Innovation Summit 2026) Roche Pharma Day 2025 Presentation Events Second Quarter 2026 Financial Results Earnings Call Aug 6, 2026 at 4:30 PM EDT Add to Outlook Add to Google Calendar Past Events COR1 Cell Therapy Program for Corneal Endothelial Disease Developmental Updates Call Jul 13, 2026 at 4:30 PM EDT Click here for webcast First Quarter 2026 Financial Results Earnings Call May 12, 2026 at 4:30 PM EDT Click here for webcast Foundation Fighting Blindness Retinal Innovation Summit 2026 May 1, 2026 Retinal Pigment Epithelium Cell Therapy in Geographic Atrophy Secondary to Age-related Macular Degeneration: 3-Year Results from the Phase 1/2a Study 2.1 MB Fourth Quarter and Full Year 2025 Financial Results Earnings Call Mar 5, 2026 at 4:30 PM EST Click here for webcast Hanson Wade 4th Ophthalmic Drug Delivery Summit Jan 27, 2026 at 4:00 PM EST Click here for webcast Hanson Wade 4th Ophthalmology Drug Delivery Summit 1.7 MB Third Quarter 2025 Financial Results Earnings Call Nov 6, 2025 at 4:30 PM EST Click here for webcast H.C. Wainwright 27th Annual Global Investment Conference Sep 8, 2025 at 11:30 AM EDT Click here for webcast Second Quarter 2025 Financial Results Earnings Call Aug 12, 2025 at 4:30 PM EDT Click here for webcast
Second Quarter 2026 Financial Results Earnings Call Aug 6, 2026 at 4:30 PM EDT Add to Outlook Add to Google Calendar
COR1 Cell Therapy Program for Corneal Endothelial Disease Developmental Updates Call Jul 13, 2026 at 4:30 PM EDT Click here for webcast
First Quarter 2026 Financial Results Earnings Call May 12, 2026 at 4:30 PM EDT Click here for webcast
Foundation Fighting Blindness Retinal Innovation Summit 2026 May 1, 2026 Retinal Pigment Epithelium Cell Therapy in Geographic Atrophy Secondary to Age-related Macular Degeneration: 3-Year Results from the Phase 1/2a Study 2.1 MB
Retinal Pigment Epithelium Cell Therapy in Geographic Atrophy Secondary to Age-related Macular Degeneration: 3-Year Results from the Phase 1/2a Study 2.1 MB
Fourth Quarter and Full Year 2025 Financial Results Earnings Call Mar 5, 2026 at 4:30 PM EST Click here for webcast
Hanson Wade 4th Ophthalmic Drug Delivery Summit Jan 27, 2026 at 4:00 PM EST Click here for webcast Hanson Wade 4th Ophthalmology Drug Delivery Summit 1.7 MB
H.C. Wainwright 27th Annual Global Investment Conference Sep 8, 2025 at 11:30 AM EDT Click here for webcast
Second Quarter 2025 Financial Results Earnings Call Aug 12, 2025 at 4:30 PM EDT Click here for webcast